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Sir—We read with interest the article by Pieter T. J. Spierings 
(2008) pertaining to the hip resurfacing expectations and limi-
tations. We would like to make some comments and discuss 
some of the conclusions of the article:
1.  For  the  conservative  approach  of  the  acetabular  bone 
stock, from our experience we do not agree that more bone is 
removed in hip resurfacing (HRA) than in total hip arthroplasty 
(THA). The author does not take into account the difference 
in gender in the indications of both procedures. That a small 
survey about sales of prostheses done among the largest dis-
tributors in the Netherlands showed that there would be more 
excessive bone loss in resurfacing is possible, but it has been 
well established in all papers about HRA and THA, that the 
majority of patients are male in HRA (70%), female in total 
hip (70%) (Buergi and Walter 2007). In general the cup size 
in females is about 6 to 8 mm smaller than the size in male 
patients, which supports our point that there is not a difference 
between the 2 procedures even in the Netherlands.
There is also a difference in bone removal of the acetabu-
lum in different implants because of different instrumentation, 
techniques and design, but this has not yet been shown to be 
statistically significant.
Vendittoli  in  a  prospective,  randomized  study  compared 
conservation of acetabular bone after THA and HRA of the 
hip (Venditolli et al. 2006). The results suggested that removal 
of bone on the acetabular side in HRA was comparable with 
that of THA, the mean or median diameters of the last reamer 
used or the mean size of the acetabular component (54.90 mm 
(44 to 64) for resurfacing arthroplasty and 54.74 mm (48 to 
62) for THR, p = 0.770. The same results were also seen in 
other studies (Naal et al. 2009). Moonot showed hip resurfac-
ing acetabular components was 2.03 mm less than that of the 
acetabular components in the uncemented total hip replace-
ments (p < 0.0001) (Moonot et al. 2008).
We will not deny that an excessively large cup is never done 
in resurfacing, but this is seen as a mistake in the resurfacing 
technique as is also the high abduction angle in cup position.
In revision of HRA it was reported that revision of HRA 
may be performed successfully with a minimal increase in 
bone loss (Ball et al. 2007, McGrath et al. 2009). In our study 
based on (42) we show that the average increase in cup diam-
eter after revision is only 1.4 mm in the hips that needed cup 
exchange.(De Haan et al. 2008)
2. That the range of motion is “clearly compromised” is not 
true. This discussion is not so simple and depends mainly on 
the head neck ratio we can find as well in THA where the head 
diameter is the most important, in HRA where the head neck 
ratio is important as is also the surgical technique. If a resurfac-
ing is well done with the correct head size, all osteophytes are 
removed, and a correct removal of bump on the neck or con-
flicting bone, the same ROM as a normal hip should be seen.
The proof used in this article with a CAD model derived from 
CT scans, or composite femurs and pelvises can not in any 
way be in conflict with daily arthroplasty practice where this 
problem is not encountered. In some clinical studies greater 
improvements in hip extension and abduction moment were 
found in HRA, indicating typical loading of the hip, compared 
to THA. Shrader in his pilot study showed that HRA group 
achieved greater hip extension through the movement cycle 
compared to the THA group, which maintained reduced (p = 
0.01) hip extension angle (Shrader et al. 2009).
That impingement problems and reduction of ROM never 
occurs in HRA we will not state, but this problem does not 
have a high incidence/prevalence.
In the literature a variety of other complications related to 
HRA can be found, including metallosis, raised metal ion levels, 
aseptic lymphocytic vasculitis associated lesions (ALVAL), 
pseudotumors,  clicking,  squeaking,  and  nerve  palsy  (Back 
et al. 2005, Lachiewicz 2007). Mabilleau give in this issue 
of Acta an overview of the literature on biological responses 
to metal-on metal HRA. They found an increasing number of 
case reports on periprosthetic soft-tissue masses and osteoly-
sis as a response to elevated metal ion levels. (Mabilleau et al. 
2008) The increased concentration of metal particles in the 
joint space of HRA could lead to a T lymphocyte-mediated 
hypersensitivity reaction (Type IV). The authors express their 
concerns about the risks of long-term exposure to metal ions. 
An increased risk of developing lymphoma in patients with 
chronic  inflammatory  disease  who  undergo  metal-on-metal 
arthoplasty has recently been considered (Lidgren 2008).
The same issues can be found with metal-on-metal total 
hips, especially in the current era of large diameter jumbo 
heads. Those are rare metal-on-metal problems, not simply 
HR problems.
Varus placement of the femoral component leads to higher 
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and Poitras 2007, Radcliffe and Taylor 2007, Lazarinis et al. 
2008). Cup anteversion greater than 25% or cup abduction 
less than 45% can result in impingement and increased wear. 
The safe zone for cup and head positioning is smaller in HRA 
than in THA, and deviations are less forgiving.
Again, this is a big diameter MoM problem – there is clear 
evidence that component design is an important determinant 
of component wear when the implant is malpositioned, so not 
all HRAs will suffer from this problem to the same extent.
Stress Shielding does occur to some extent in all Hip replace-
ments but the degree and clinical consequences are highly vari-
able according to confounding factors including initial bone 
stock, vascularity, fixation and biomechanical integrity of the 
construct. Analysis of long-term retrieved specimens (up to 23 
years) shows that this is not inevitable or clinically consequen-
tial in many well performed HRAs. Indeed, these long terms 
specimen often show remarkable remodelling and adaptation, 
even in female patients (Kordi and McMinn 2009).
Dr Spierings points out that Hing et al. “measured more than 
10% thinning in 28% of his patients.” which sounds alarming. 
However, in her paper, Dr Hing concluded that “narrowing 
of the femoral neck which is found with the Birmingham hip 
resurfacing arthroplasty is in most cases associated with no 
adverse clinical or radiological outcome up to a maximum of 
six years after the initial operation” (Hing et al. 2007).
We agree that Patients are best served with proven designs 
that have proven long-term outcome.” With greater than 10 
year follow-up in the first two HRA designs, and with excel-
lent results in a difficult group of patients, there are proven 
designs of HRA available for surgeons willing to undergo the 
training to become specialist resurfacing surgeons.
We do also agree that easy resurfacing does not exist, even 
in experienced hands. Hip resurfacing arthroplasty only finds 
its place in high volume centres and experienced surgeons. A 
heart transplant is not done by a general surgeon, but only in 
a specialised centre. 
K De Smet, and A Calistri
Department of Orthopaedics, ANCA Medical Centre,
Krijgslaan 181, BE-9000 Ghent, Belgium
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Sir—Thanks for the letter with comments from Drs. De Smet 
and Calistri in which they discuss various topics of my guest 
editorial.
1. More acetabular bone loss in HRA. Data obtained from 
Dutch distributors showed a difference of approximately 6 mm 
between the cup diameter of a total hip arthroplasty (THA) and 
a hip resurfacing arthroplasty (HRA). De Smet and Calistri 
claim this difference is due to a difference in sex ratio between 
THA and HRA. They refer to an article using data from the 
2005 Australian National Joint Replacement registry. In this 
registry the male/female percent ratio for HRA is 44/56 and 
for THA 73/27. The difference in the average acetabular cup 
diameter between males and females is 4–5 mm (Moonot et al. 
2008, Naal et al. 2009). Simple calculations then shows that 
the difference in sex ratio between THA and HRA accounts 
only for 29% × 4.5 mm = 1.3 mm diameter difference. This 
means that the remaining 4.7 mm or 78% of the difference in 
cup diameter between THA and HRA must be contributed to 
the surgical procedure.
Publications  have  shown  differences  between  THA  and 
HRA cup diameter. Vendittoli et al. (2006) found no differ-
ence in cup diameter. Moonot et al. (2008) found in an age 
and sex matched cohort no difference in cup diameter for men, 
and for women a 2 mm smaller cup diameter in HRA, than for 
uncemented THA. Naal et al. (2009) not only matched for age 
and sex but also for height and weight, which are associated 
with the cup diameter. They found that HRA required, for both 
men and women, a 2 mm larger acetabular component than 
uncemented THA. Loughead et al. (2006) found a 5 mm larger 
cup diameter for HRA than for THA.
Certainly surgical technique and skill plays a major role in 
the outcome of these studies. In the Netherlands no centers 
exist which are fully committed to resurfacing arthroplasty 
and taking into account that only 6% of all hip patients qual-
ify for a HRA it is clear that only few surgeons will have the 
opportunity to gain sufficient experience. Less experienced 
surgeons will try to avoid notching to decrease the risk of 
femoral neck fracture and will probably use a larger femoral 
component than an experienced surgeon. Therefore it may be 
expected that acetabular bone loss for HRA will be higher in 
a nationwide survey than presented in studies of single high-
volume centers.
2. Compromised range of motion. There is no doubt that the 
natural femoral neck diameter in HRA is larger than the pros-
thetic neck diameter in THA. With a given head diameter size 
this results in a decreased range of motion (ROM) in flexion 
and combined flexion-adduction- endorotation movements. I 
agree that in most cases the decreased ROM will not be noticed 
clinically and that a sufficient ROM can be achieved. In some 
cases however it may lead to impingement and subluxation 
which for a metal on metal bearing is most undesirable. Sub-
luxation will lead to increased wear and metallosis.
3. Metal on metal. De Smet and Calistri state that many of 
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caused by HRA itself but are caused by the metal on metal 
bearing surfaces. This observation is correct. Unfortunately 
metal on metal is the only bearing material available for resur-
facing prostheses. In many cases metal on metal is an excel-
lent  choice  with  a  successful  long-term  outcome.  In  some 
cases, in particular when component positioning and range 
of motion are critical, metal on metal is a less good choice. 
Metal on metal is very unforgiving as soon as circumstances 
become less from optimal. Metal on metal impingement will 
cause excessive wear as does subluxation. Steep cup position-
ing will lead to rim loading and stripe wear. The combination 
of critical positioning, reduced ROM and metal on metal is 
not ideal, but metal on metal is the only choice for HRA. Any 
other bearing material would need a thicker acetabular cup 
wall thickness and therefore a larger cup diameter.
De Smet and Calistri work in a clinic fully specialized in 
HRA. In such a an ideal setting there is no learning curve 
and type of implant, instrumentation, bone preparation and 
cementing technique can be optimized. Their long term sur-
vival rate surely must be better than the numbers of a national 
register. In the 2008 Australian Registry, presenting the results 
of 2007, the use of HRA has decreased for the second year. 
Together with an increasing number of all primary hips, the 
percentage of resurfacing has decreased to 7%. The revison 
rate for this selected patient group remains high. The 1-year 
revision rate for HRA is 1.9% compared to 1.1% for cemented 
THA. The 7-year revision rate is 5.4% for HRA compared to 
3.8% for cemented THA. HRA has a significantly higher revi-
sion rate compared to THA with a hazard ratio (adjusted for 
sex and age) of 1.4. Up to now there is no evidence that THA 
can improve the short-, medium- or long-term results obtained 
with conventional total hips.
Pieter T.J. Spierings
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